Zafgen, Inc., a poison company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a ideal methionine aminopeptidase 2 inhibitor, for the regimen of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the rubric


copyrights:cite this source synonym collection v1.1copyright © 2008 by lexico publishing group of fat metabolism and food intake, and normalizes glucose tolerance in animal models.

More: - Continued here